Pictet Asset Management Holding Sa Alnylam Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 664,722 shares of ALNY stock, worth $168 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
664,722
Previous 758,528
12.37%
Holding current value
$168 Million
Previous $184 Million
0.8%
% of portfolio
0.21%
Previous 0.22%
Shares
5 transactions
Others Institutions Holding ALNY
# of Institutions
644Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$4.18 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$3.2 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.42 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.33 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.25 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.1B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...